A overview of ocular leprosy after 2 decades of multidrug therapy.
Kilimanjaro Centre for Community Ophthalmology, Moshi, Tanzania.
Susan
S
Lewallen
Paul
P
Courtright
D002991:Clofazimine / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D015818:Eye Infections, Bacterial / Q000188:drug therapy / Q000453:epidemiology*; D014943:Global Health; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use*; D007918:Leprosy / Q000188:drug therapy / Q000453:epidemiology*; D009166:Mycobacterium leprae / Q000502:physiology*; D012293:Rifampin / Q000627:therapeutic use
D007917:Leprostatic Agents; D003622:Dapsone; D002991:Clofazimine; D012293:Rifampin